Millendo Therapeutics, Inc. MLND

Set alert

Price alert · MLND

All alert types
1.06 +1.06 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
20.19M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-2.26
Beta
0.48
Short ratio
0.98
Inst. own
37.18%
Dividend
0.00
Ex-div date
Earnings
Jul 2, 2021
50-d avg
18.86
200-d avg
25.14
1y target
2.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for MLND has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-35.18 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.2×
FY 2013: -0.0×FY 2014: -0.0×FY 2015: -0.0×FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.1×FY 2020: -0.1×FY 2024: -0.7×FY 2025: -0.2×
FY 2013 5y median -0.1× FY 2025
P/S 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 4.3×FY 2016: 2.2×FY 2017: 5.4×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2013 5y median 0.0× FY 2025
P/B 0.7×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2024: 1.5×FY 2025: 0.7×
FY 2013 5y median 0.1× FY 2025
P/FCF 0.0×
FY 2013: -0.0×FY 2014: -0.0×FY 2015: -0.0×FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.1×FY 2020: -0.1×FY 2024: -68.0×FY 2025: 0.0×
FY 2013 5y median -0.1× FY 2025
EV/EBITDA 18.2×
FY 2013: 0.6×FY 2014: 0.1×FY 2015: 0.6×FY 2016: 0.5×FY 2017: 0.3×FY 2018: 2.7×FY 2019: 1.2×FY 2020: 0.9×FY 2024: 37.7×FY 2025: 18.2×
FY 2013 5y median 2.7× FY 2025
EV/Sales 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: -152×FY 2016: -65.1×FY 2017: -47.9×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2013 5y median 0.0× FY 2025
FCF Yield 0.0%
FY 2013: -2619.4%FY 2014: -3317.5%FY 2015: -4611.7%FY 2016: -4501.6%FY 2017: -2882.8%FY 2018: -2888.4%FY 2019: -675.8%FY 2020: -1131.9%FY 2024: -1.5%FY 2025: 0.0%
FY 2013 5y median -675.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: -711.9%FY 2016: -727.1%FY 2017: -167.8%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2013 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: -25992.4%FY 2016: -11579.2%FY 2017: -15788.5%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2013 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: -26432.9%FY 2016: -12597.2%FY 2017: -17279.7%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2013 5y median 0.0% FY 2025
ROE -393.9%
FY 2013: -69.6%FY 2014: -89.5%FY 2015: -57.7%FY 2016: -76.0%FY 2017: -79.3%FY 2018: -37.2%FY 2019: -74.4%FY 2020: -107.9%FY 2024: -218.8%FY 2025: -393.9%
FY 2013 5y median -107.9% FY 2025
ROIC 0.0%
FY 2013: -69.7%FY 2014: -86.5%FY 2015: -56.5%FY 2016: -69.2%FY 2017: -71.6%FY 2018: -35.9%FY 2019: -70.5%FY 2020: -98.8%FY 2024: 0.0%FY 2025: 0.0%
FY 2013 5y median -35.9% FY 2025
ROA -155.1%
FY 2013: -61.1%FY 2014: -75.5%FY 2015: -52.8%FY 2016: -67.1%FY 2017: -70.0%FY 2018: -32.3%FY 2019: -59.4%FY 2020: -83.9%FY 2024: -100.9%FY 2025: -155.1%
FY 2013 5y median -83.9% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 135.7%FY 2017: -54.8%FY 2018: -100.0%FY 2019: 0.0%FY 2020: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2013 FY 2025
Operating Income 0.0%
FY 2013: -115.3%FY 2014: -64.5%FY 2015: -50.2%FY 2016: -5.0%FY 2017: 38.4%FY 2018: 42.3%FY 2019: -68.9%FY 2020: 20.8%FY 2024: 0.0%FY 2025: 0.0%
FY 2013 FY 2025
EPS (diluted) -322.0%
FY 2013: 22.7%FY 2014: -21.7%FY 2015: -23.6%FY 2016: 5.3%FY 2017: 44.2%FY 2018: 18.0%FY 2019: 81.5%FY 2020: 40.6%FY 2024: 0.0%FY 2025: -322.0%
FY 2013 FY 2025
Free Cash Flow 100.0%
FY 2013: -56.7%FY 2014: -77.5%FY 2015: -66.3%FY 2016: -15.9%FY 2017: 28.9%FY 2018: 48.2%FY 2019: -75.7%FY 2020: 26.8%FY 2024: 0.0%FY 2025: 100.0%
FY 2013 FY 2025

Financial Health

Current Ratio 2.5×
FY 2013: 7.8×FY 2014: 6.1×FY 2015: 11.6×FY 2016: 8.8×FY 2017: 8.8×FY 2018: 8.5×FY 2019: 5.7×FY 2020: 5.1×FY 2024: 2.2×FY 2025: 2.5×
FY 2013 5y median 5.1× FY 2025
Quick Ratio 2.5×
FY 2013: 7.8×FY 2014: 6.1×FY 2015: 11.6×FY 2016: 8.8×FY 2017: 8.8×FY 2018: 8.5×FY 2019: 5.7×FY 2020: 5.1×FY 2024: 2.2×FY 2025: 2.5×
FY 2013 5y median 5.1× FY 2025
Debt / Equity 1.2×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2024: 0.8×FY 2025: 1.2×
FY 2013 5y median 0.1× FY 2025
Net Debt / EBITDA 1.6×
FY 2013: 0.6×FY 2014: 0.1×FY 2015: 0.6×FY 2016: 0.6×FY 2017: 0.3×FY 2018: 2.7×FY 2019: 1.3×FY 2020: 1.0×FY 2024: -38.3×FY 2025: 1.6×
FY 2013 5y median 1.3× FY 2025
Interest Coverage 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: -201×FY 2019: 43.7×FY 2020: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2013 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2013 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2013 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31